Mountainside, NJ, United States of America

Gary Olson

This inventor holds 31 USPTO granted patents and 6 published patent applications and 6 EPO patents. Top assignees: Praecis Pharmaceuticals, Inc., Oncoceutics, Inc., Provid Pharmaceuticals Inc.. Active years: 2003-2026.

USPTO Granted Patents = 31 (Patent Applications = 6)

% Patents Active = 54.8

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 375(Granted Patents)

Location History:

Moutainside, NJ (US) (2008)
Monmouth Junction, NJ (US) (2016 - 2017)
Mountainside, NJ (US) (2003 - 2024)

Company Filing History:

10 out of 43

Praecis Pharmaceuticals, Inc.

Provid Pharmaceuticals Inc.

patents

4. 3 out of 82

Supernus Pharmaceuticals, Inc.

Rutgers, The State University of New Jersey

patents

8. 1 out of 513

Albert Einstein College of Medicine

patents

9. 1 out of 1

Corridor Pharmaceuticals, Inc.

patent

10. 1 out of 68

Palatin Technologies Incorporated

University of California

patents

13. 1 out of 2,645

University of Pennsylvania

patents

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709602 - INTERMEDIATES FOR MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES (2026-08-18),

2. 12454535 - Substituted derivatives of isoindoles (2025-10-28),

3. 11976068 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2024-05-07),

4. 11964951 - Process of making derivatives of substituted morpholines (2024-04-23),

5. 10266533 - 7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2019-04-23),

6. 10118936 - Arginase inhibitors and methods of use (2018-11-06),

7. 9845324 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2017-12-19),

8. 9592221 - Antibacterial agents: aryl myxopyronin derivatives (2017-03-14),

9. 9447122 - Arginase inhibitors and methods of use thereof (2016-09-20),

10. 9376437 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy (2016-06-28),

11. 9315495 - Antibacterial agents: aryl myxopyronin derivatives (2016-04-19),

12. 9265765 - 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy (2016-02-23),

13. 8952150 - Prostaglandin transporter inhibitors and uses thereof (2015-02-10),

14. 8894970 - Arginase inhibitors and methods of use thereof (2014-11-25),

15. 8598312 - Inhibitors of antigen presentation by MHC class II molecules (2013-12-03),

Title: Gary Olson: Pioneering Inventor from Mountainside, NJ

Introduction: Gary Olson is a distinguished inventor hailing from Mountainside, NJ, known for his groundbreaking contributions to various industries.

Latest Patents: Gary Olson holds several patents in the fields of technology and healthcare, with his most recent inventions focusing on sustainable energy solutions and medical devices.

Career Highlights: Throughout his illustrious career, Gary Olson has been recognized for his innovative spirit and problem-solving skills, leading to the development of cutting-edge products that have revolutionized the way we live and work.

Collaborations: Gary Olson has collaborated with leading research institutions, universities, and companies to bring his ideas to life, fostering a culture of creativity and excellence in the innovation community.

Conclusion: Gary Olson's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology and beyond.